Apr 18, 2026
President Trump signs executive order directing $50 million and expedited FDA review for psilocybin and ibogaine as mental-health treatments
President Donald Trump signed an executive order directing $50 million in federal funds to increase access to certain psychedelic drugs for treatment of mental healt...